Skip to main content
Equibles

DAFNA Capital Management LLC

Position in PYPD — PolyPid Ltd.

CIK 1389933 LOS ANGELES, CA
Back to PYPD Full portfolio

Position in PYPD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,056,132
+$145,530 QoQ
Shares Held
207,900
0.0% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#3
of 33 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PYPD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. PYPD ranks #45 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in PYPD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,056,132 207,900
2026-03-31 $910,602 207,900
2025-12-31 $902,286 207,900
2025-09-30 $693,346 207,900
2025-06-30 $733,887 207,900
2025-03-31 $789,349 291,273
2024-12-31 $885,469 291,273
2024-09-30 $1,061,229 308,497
2024-06-30 $794,837 184,846
2024-03-31 $853,051 185,446